Home Other Building Blocks 522-40-7
522-40-7,MFCD00867397
Catalog No.:AA00DIAS

522-40-7 | (E)-Hex-3-ene-3,4-diylbis(4,1-phenylene) bis(dihydrogen phosphate)

This product is typically in stock,please click "Inquire" below or
contact us at [email protected] for pricing and availability information.
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00DIAS
Chemical Name:
(E)-Hex-3-ene-3,4-diylbis(4,1-phenylene) bis(dihydrogen phosphate)
CAS Number:
522-40-7
Molecular Formula:
C18H22O8P2
Molecular Weight:
428.3100
MDL Number:
MFCD00867397
SMILES:
CC/C(=C(\c1ccc(cc1)OP(=O)(O)O)/CC)/c1ccc(cc1)OP(=O)(O)O
UN Number:
3249
Properties
Computed Properties
 
Complexity:
568  
Covalently-Bonded Unit Count:
1  
Defined Bond Stereocenter Count:
1  
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
4  
Rotatable Bond Count:
8  
XLogP3:
2.5  

Literature

Title: Anticancer effect of combination therapy of VP16 and fosfesterol in hormone-refractory prostate cancer.

Journal: American journal of clinical oncology 20080401

Title: [Androgen-independent prostate cancer with bone metastasis successfully treated by intravenous administration of zoledronic acid and diethylstilbestrol diphosphate].

Journal: Hinyokika kiyo. Acta urologica Japonica 20071201

Title: Absence of Bcl-2 expression favors response to the short-term administration of diethylstilbestrol diphosphate in prostate Cancer.

Journal: The Prostate 20061201

Title: Clinical experience of hormone therapy to bone metastatic prostate cancer.

Journal: International journal of urology : official journal of the Japanese Urological Association 20060501

Title: Assay of the synthetic estrogen fosfestrol in pharmaceutical formulations using capillary electrophoresis.

Journal: Journal of pharmaceutical and biomedical analysis 20050915

Title: [Primary, nonviral, hepatocellular carcinoma in patients with prostate cancer treated by hormone therapy: 2 case reports].

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20050501

Title: Role of estrogens in the secondary hormonal manipulation of hormone refractory prostate cancer.

Journal: JPMA. The Journal of the Pakistan Medical Association 20040901

Title: Rotational 3D-conformal radiation therapy (conformation therapy) combined with hormone therapy for the treatment of stage B2/C prostate cancer in Japanese men.

Journal: International journal of radiation oncology, biology, physics 20030501

Title: How to manage hot flashes in prostate cancer?

Journal: Postgraduate medicine 20030501

Title: Complete regression of bone metastases on super bone scan, by low-dose cisplatin, UFT, diethylstilbestrol diphosphate, and dexamethasone in a patient with hormone-refractory prostate cancer.

Journal: International journal of clinical oncology 20030401

Title: [Decrease in anticoagulant factors in patients with prostate cancer treated with diethylstilbestrol diphosphate].

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20030301

Title: [Two cases of prostate cancer associated with acute myeloid leukemia presenting as thrombocytopenia during endocrine therapy].

Journal: Hinyokika kiyo. Acta urologica Japonica 20030201

Title: Cell proliferation, apoptosis and prognosis in patients with metastatic prostate cancer.

Journal: Anticancer research 20030101

Title: [Estrogen therapy--high-dose intravenous diethylstilbestrol diphosphate therapy for advanced or hormone refractory prostate cancer].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20021201

Title: Estrogen treatment of prostate cancer increases triglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques.

Journal: Clinica chimica acta; international journal of clinical chemistry 20020301

Title: Morphology of accessory sex organs from neonatally DES- and DES-dp-injected mouse.

Journal: Okajimas folia anatomica Japonica 20020301

Title: Low serum testosterone level predicts worse response to endocrine therapy in Japanese patients with metastatic prostate cancer.

Journal: Endocrine journal 20020201

Title: The pharmacokinetics of fosfestrol and diethylstilbestrol in chronic hemodialysis patients with prostate cancer.

Journal: International journal of urology : official journal of the Japanese Urological Association 20011201

Title: Moderate dose diethylstilbestrol diphosphate therapy in hormone refractory prostate cancer.

Journal: Scandinavian journal of urology and nephrology 20010901

Title: Prostate adenocarcinoma producing syndrome of inappropriate secretion of antidiuretic hormone.

Journal: International journal of urology : official journal of the Japanese Urological Association 20010901

Title: [Suppressive effects of the antiandrogen flutamide on adrenal androgens in advanced prostate cancer patients].

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20010101

Title: Prospective and randomized comparison of combined androgen blockade versus combination with oral UFT as an initial treatment for prostate cancer.

Journal: Japanese journal of clinical oncology 20010101

Title: [Liver disorder owing to estrogen therapy in prostatic cancer, examined histopathologically in six autopsy cases].

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 19891201

Title: Adverse effects during endocrine therapy for prostatic carcinoma with a high dose of estrogen.

Journal: Urologia internationalis 19850101

Title: Chemohormonal therapy of metastatic prostate cancer. A pilot study.

Journal: Cancer 19830801

Title: Diethylstilbestrol-diphosphate-induced disseminated intravascular coagulation in prostatic carcinoma.

Journal: Southern medical journal 19820201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:522-40-7 Molecular Formula|522-40-7 MDL|522-40-7 SMILES|522-40-7 (E)-Hex-3-ene-3,4-diylbis(4,1-phenylene) bis(dihydrogen phosphate)